Related Experiment Video
Updated: Sep 29, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models.
C Kavitha1, Vinodhini Mani1, S R Srividhya1
1Department of Computer Science and Engineering, Sathyabama Institute of Science and Technology, Chennai, India.
Frontiers in Public Health
|March 21, 2022
Summary
Machine learning models can predict Alzheimer's disease (AD) early. This study achieved 83% accuracy, aiding clinical diagnosis and potentially lowering mortality rates for this neurodegenerative condition.
Area of Science:
- Neuroscience
- Medical Informatics
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, impacting a growing global population.
- Early diagnosis of AD is challenging but crucial for effective treatment and minimizing neurodegeneration.
- Increasing AD incidence poses significant social, financial, and economic burdens.
Purpose of the Study:
- To apply machine learning (ML) techniques for accurate prediction of Alzheimer's disease.
- To identify optimal ML parameters for early AD detection.
- To provide clinicians with a tool for improved AD diagnosis.
Main Methods:
- Utilized several ML algorithms including Decision Tree, Random Forest, Support Vector Machine, Gradient Boosting, and Voting classifiers.
- Employed the Open Access Series of Imaging Studies (OASIS) dataset for AD prediction.
- Evaluated model performance using metrics such as Precision, Recall, Accuracy, and F1-score.
Main Results:
- The proposed ML classification scheme achieved a high average accuracy of 83% on test data.
- The achieved accuracy significantly outperforms existing methods for AD prediction.
- The models demonstrated strong performance in identifying key parameters for AD diagnosis.
Conclusions:
- Machine learning offers a promising approach for the early and accurate prediction of Alzheimer's disease.
- Early diagnosis via ML can lead to more effective treatments and reduced mortality.
- The developed classification scheme can support clinical decision-making in AD diagnosis.
Related Concept Videos
Alzheimer's Disease: Overview
709
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
709
Alzheimer's Disease: Treatment
276
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
276

